Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar;48(3):191-197.
doi: 10.4070/kcj.2018.0074.

Treatment of Femoropopliteal Artery In-stent Restenosis

Wonho Kim  1 , Donghoon Choi  2
Affiliations
Review

Treatment of Femoropopliteal Artery In-stent Restenosis

Wonho Kim et al. Korean Circ J. 2018 Mar.

Abstract

Femoropopliteal (FP) artery-in stent restenosis (ISR) is a daunting management problem that we continue to face. FP artery-ISR rates after primary stent implantation are relatively high. Although repeat FP artery-ISR and the need for additional interventions remain all too common, little consensus exists regarding the best treatment algorithm. In this article, we review the limitations of the currently used devices for the endovascular treatment of FP artery-ISR and discuss which strategies are the most effective and safe.

Keywords: Peripheral artery disease.

PubMed Disclaimer

Conflict of interest statement

The authors have no financial conflicts of interest.

Figures

Figure 1
Figure 1
Freedom from TLR at one year in patients with FP artery-ISR. DEBATE-ISR = Drug-Eluting Balloon in peripherAl inTErvention for In-Stent Restenosis; FAIR = Femoral Artery In-Stent Restenosis; FP = femoropopliteal; ISR = in stent restenosis; TLR = target lesion revascularization.
Figure 2
Figure 2
Combination of mechanical atherectomy and DEB angioplasty for FP artery-ISR. (A) Stented fully occluded distal to mid superficial femoral artery. (B) Two passes blades-down, 2 passes blades-up with JetStream atherectomy device. (C) Follow-up angiogram showing residual stenoses. (D) Blood flow fully restored after DEB angioplasty. DEB = drug-eluting balloon; FP = femoropopliteal; ISR = in stent restenosis.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Shammas NW. An overview of optimal endovascular strategy in treating the femoropopliteal artery: mechanical, biological, and procedural factors. Int J Angiol. 2013;22:1–8. - PMC - PubMed
    1. Tosaka A, Soga Y, Iida O, et al. Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol. 2012;59:16–23. - PubMed
    1. Ko YG, Ahn CM, Min PK, et al. Baseline characteristics of a retrospective patient cohort in the Korean Vascular Intervention Society Endovascular Therapy in Lower Limb Artery Diseases (K-VIS ELLA) Registry. Korean Circ J. 2017;47:469–476. - PMC - PubMed
    1. Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation. 1996;94:1247–1254. - PubMed
    1. Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation. 1999;100:1872–1878. - PubMed

LinkOut - more resources